Indivior Pharmaceuticals vs Trulieve Cannabis
Indivior Pharmaceuticals and Trulieve Cannabis are similar in size: $1.24bn and $1.18bn of revenue in their latest fiscal years. Indivior Pharmaceuticals grew faster (4.3% against -0.4%). Indivior Pharmaceuticals kept more of each dollar of sales as profit: a net margin of 16.9% against -9.9%.
| Latest fiscal year | Indivior PharmaceuticalsINDV, 2025 | Trulieve CannabisTRLV, 2025 |
|---|---|---|
| Revenue | $1.24bn | $1.18bn |
| Revenue growth | 4.3% | -0.4% |
| Net income | $210m | −$116m |
| Operating margin | 21.1% | 12.1% |
| Net margin | 16.9% | -9.9% |
| Return on equity | — | -9.7% |
| Free cash flow | −$93.0m | $229m |
| Cash | $195m | $256m |
| Total debt | $319m | $141m |
| Debt to equity | — | 12.3% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | $11.0m | — |
| Employees | 838 | 5,000 |
| Market value | $4.43bn | $2.20bn |
| Price vs our value range | Above our value range | Below our value range |
| Moat score | — | 28 (Weak) |
| Insider trades, 12 months | 10 buys, 3 sales | 0 buys, 7 sales |